Remdesivir costs about $1 a day to make, and the CEO of the company that developed it, Gilead, said the firm is committed to ensuring ‘access’ to the drug The US Food and Drug Administration has approved the Ebola drug remdesivir for emergency use on hospitalized coronavirus patients. President Donald Trump announced Friday that doctors … Read more
The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it. ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more
Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients with ‘nearly all’ discharged within a week. University of Chicago Medicine recruited 125 people with COVID-19 as part of Gilead Science’s clinical trials. Of those people, 113 had severe disease. All the patients were been treated with daily infusions of remdesivir. Most of them … Read more